Tarsons Products Ltd
Tarsons Products Ltd. (TPL) is an Indian labware company engaged in the designing, development, manufacturing, and marketing of 'consumables', 'reusables' and 'others' including benchtop equipment, used in various laboratories across research organizations, academia institutes, pharmaceutical companies, Contract Research Organizations, Diagnostic companies, and hospitals[1]
- Market Cap ₹ 2,474 Cr.
- Current Price ₹ 465
- High / Low ₹ 646 / 390
- Stock P/E 24.6
- Book Value ₹ 92.1
- Dividend Yield 0.00 %
- ROCE 35.3 %
- ROE 27.4 %
- Face Value ₹ 2.00
Pros
- Company has reduced debt.
- Company is almost debt free.
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Miscellaneous Industry: Miscellaneous
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2021 | Mar 2022 | |
---|---|---|
229 | 301 | |
125 | 148 | |
Operating Profit | 103 | 153 |
OPM % | 45% | 51% |
5 | 8 | |
Interest | 3 | 4 |
Depreciation | 14 | 22 |
Profit before tax | 92 | 135 |
Tax % | 25% | 25% |
69 | 101 | |
EPS in Rs | 3,583.25 | 18.92 |
Dividend Payout % | 0% | 0% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | 31% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | 46% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
1 Year: | -12% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
Last Year: | 27% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2021 | Mar 2022 | |
---|---|---|
Equity Capital | 0 | 11 |
Reserves | 244 | 479 |
34 | 22 | |
18 | 33 | |
Total Liabilities | 296 | 544 |
120 | 189 | |
CWIP | 22 | 32 |
Investments | 0 | 0 |
153 | 323 | |
Total Assets | 296 | 544 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2021 | Mar 2022 | |
---|---|---|
68 | 83 | |
-64 | -138 | |
-27 | 130 | |
Net Cash Flow | -23 | 75 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2021 | Mar 2022 | |
---|---|---|
Debtor Days | 75 | 79 |
Inventory Days | 277 | 478 |
Days Payable | 35 | 75 |
Cash Conversion Cycle | 317 | 482 |
Working Capital Days | 108 | 150 |
ROCE % | 35% |
Documents
Announcements
- Compliance Certificate Under Reg 40(10) For The Year Ended 31St March, 2024 12 Apr
- Compliance Certificate Under Reg 7(3) For The Year Ended 31St March, 2024 12 Apr
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 12 Apr
- Closure of Trading Window 22 Mar
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
12 Mar - Of Schedule of Analyst / Institutional Investor meetings under the SEBI (LODR), Regulations 2015
Concalls
-
Feb 2024Transcript PPT REC
-
Feb 2024TranscriptNotesPPT
-
Dec 2023TranscriptPPTREC
-
Nov 2023Transcript PPT REC
-
Aug 2023Transcript PPT
-
Jun 2023Transcript PPT
-
Feb 2023Transcript PPT
-
Nov 2022Transcript PPT
-
Aug 2022Transcript PPT
-
Jun 2022Transcript PPT
-
Feb 2022Transcript PPT
India’s Leading Labware Company
One of the leading Indian labware company engaged in designing, development, manufacturing and marketing of consumables, reusables and others (including benchtop
equipment & instruments) [1]